What is OpenBiome?
OpenBiome Foundation is a pioneering organization dedicated to broadening patient access to microbiome therapies and fostering groundbreaking scientific research in health. The company's primary focus is on addressing Clostridioides difficile (C. diff) infections by offering safe access to investigational fecal microbiota transplantation (FMT) therapy. Through strategic partnerships and the provision of open-access resources, OpenBiome empowers clinicians, researchers, and healthcare systems with the essential tools to leverage the therapeutic potential of the human microbiome. Their mission is to ensure universal patient access to effective treatments while simultaneously driving innovation in microbiome science.
How much funding has OpenBiome raised?
OpenBiome has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in OpenBiome
PPP
Public-Private Partnership
What's next for OpenBiome?
With the recent major strategic investment, OpenBiome is poised to significantly scale its operations and deepen its impact on patient care and scientific advancement. This capital infusion is expected to fuel further research into novel microbiome-based treatments, enhance the accessibility of existing therapies like FMT, and strengthen collaborations with healthcare providers and research institutions. The company's trajectory suggests a continued focus on innovation, aiming to solidify its position as a leader in the burgeoning field of microbiome therapeutics and research, ultimately contributing to a future where these therapies are standard of care.
See full OpenBiome company page
